Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Short term Debt (2018 - 2025)

Cosmos Health's Short term Debt history spans 8 years, with the latest figure at $9.2 million for Q4 2025.

  • Quarterly results put Short term Debt at $9.2 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $9.2 million (changed N/A YoY), and the annual figure for FY2025 was $9.2 million, changed.
  • Short term Debt for Q4 2025 was $9.2 million at Cosmos Health, up from $7.6 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $12.1 million in Q2 2022 to a low of $5379.0 in Q1 2024.
  • The 5-year median for Short term Debt is $5.8 million (2022), against an average of $4.9 million.
  • The sharpest move saw Short term Debt tumbled 99.6% in 2024, then skyrocketed 135712.92% in 2025.
  • Year by year, Short term Debt stood at $1.0 million in 2021, then skyrocketed by 475.87% to $5.8 million in 2022, then rose by 15.13% to $6.6 million in 2023, then plummeted by 99.68% to $21158.0 in 2024, then soared by 43276.9% to $9.2 million in 2025.
  • According to Business Quant data, Short term Debt over the past three periods came in at $9.2 million, $7.6 million, and $8.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.